Acta Scientific Cancer Biology (ASCB)

Short Communication Volume 4 Issue 6

Revolution of Oncology 2020. Targeted Therapies based on the Genomics of Each Patient

Adrian Pablo Hunis*

Clinical Oncologist, Department of Oncology, Argentina

*Corresponding Author: Adrian Pablo Hunis, Clinical Oncologist, Department of Oncology, Argentina.

Received: February 21, 2020; Published: May 13, 2020


 We know that cancer is not a disease, but more than 200 different types of tumours, and that its diversity is not depleted in the type of tumour. Thus, three people with lung cancer, for example, will benefit from three different treatments. And one with gastric cancer can respond to a medication used in breast cancer.



Citation: Adrian Pablo Hunis. “Revolution of Oncology 2020. Targeted Therapies based on the Genomics of Each Patient”.Acta Scientific Cancer Biology 4.6 (2020): 08-11.


Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US